Thanks, Trent. We are really excited to have you on-board in this newly created role as we continue aligning key personnel with our company’s RxEvolution strategy. And as a member of our senior team, Trent will play an essential role for our company, not only by leading our Investor Relations and Treasury efforts, but also overseeing the enhancements of our environmental, social and governance policies, which are more important than ever in this environment. I want to just thank Byron Purcell for all the great work he has done in covering both IR and Treasury during a really busy time for our company. And as a crucial member of our go forward team, Byron will continue serving as Treasurer and will be working closely with Trent to help drive our business forward.

Now let's turn our attention to our results for Q2, and the progress we're making to bring our new RxEvolution strategy to life. As a company, we're taking significant steps in our journey to revolutionize our industry and elevate our role as an indispensable healthcare provider. Whether in retail pharmacy, mail order or specialty pharmacy, we're focused on fulfilling our critical role on the frontlines of healthcare, providing life-saving medications, clinical services and immunity support during a time when our communities and customers need immunity and clinical care the most. We’re aggressively accelerating the key initiatives that will drive our transformation through the RxEvolution strategy, which focuses on becoming a dominant mid-market PBM, unlocking the value of our pharmacists and revitalizing our retail and digital experiences.

READ FULL ARTICLE HERE